Spark BioLab and Aegis Asset Management to Launch 'Life Sciences Real Estate Project'

Joint Development of Specialized Life Sciences Facilities

Spark BioLab, a subsidiary of Spark Lab Group, announced on the 17th that it has signed a business agreement with Aegis Asset Management to establish and operate dedicated infrastructure for life sciences companies.

This agreement aims to lay the foundation for the sustainable growth of the domestic life sciences industry by combining Spark BioLab's capabilities in nurturing biotech startups and managing spaces with Aegis Asset Management's expertise in real estate development and operations.

Hongju Lee, CEO of Spark BioLab, and Gwansik Yoon, Executive Director of Aegis Asset Management, are posing for a commemorative photo at the business agreement ceremony. Spark Lab

Under the agreement, the two companies will jointly identify and develop facilities specialized for the life sciences industry, including research and laboratory spaces equipped with state-of-the-art equipment, clean rooms dedicated to clinical and preclinical testing, and ultra-low temperature logistics facilities for reagent and sample storage. These facilities will be provided to biotech startups at reasonable costs.

Hongju Lee, CEO of Spark BioLab, stated, "The growth of the biotech industry requires not only research and investment, but also advanced infrastructure. Through our collaboration with Aegis Asset Management, we will support domestic biotech startups so they can grow in a research and business environment that meets global standards."

This content was produced with the assistance of AI translation services.